Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ACT NOW Longitudinal Study: Outcomes of Babies With Opioid Exposure Study

NCT04149509 is registered in ClinicalTrials.gov with Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program as lead sponsor.

NCT NCT04149509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04149509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ACT NOW Longitudinal Study: Outcomes of Babies With Opioid Exposure Study
Lead sponsor
Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program
Phase
Observational
Overall status
Active, not recruiting
Start date
August 19, 2020
Completion date
December 31, 2026
Enrollment
300 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal opioid withdrawal syndrome